https://www.newpharmaitaly.it/pharmaengine-inc-and-sentinel-oncology-limited-enter-into-an-exclusive-collaboration-and-license-agreement-for-sol-578-a-chk1-inhibitor/ Il portale delle news in ambito farmaceutico Fri, 04 Dec 2020 10:47:06 +0000 hourly 1 https://wordpress.org/?v=6.9.4